Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Prepaid Assets (2016 - 2025)

Cardiff Oncology (CRDF) has disclosed Prepaid Assets for 15 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 35.23% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, down 35.23% year-over-year, with the annual reading at $1.6 million for FY2025, 35.23% down from the prior year.
  • Prepaid Assets hit $1.6 million in Q4 2025 for Cardiff Oncology, up from $956000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $6.0 million in Q1 2022 to a low of $956000.0 in Q3 2025.
  • Historically, Prepaid Assets has averaged $3.0 million across 5 years, with a median of $2.5 million in 2021.
  • Biggest five-year swings in Prepaid Assets: soared 205.07% in 2021 and later plummeted 56.14% in 2023.
  • Year by year, Prepaid Assets stood at $4.8 million in 2021, then increased by 9.96% to $5.2 million in 2022, then tumbled by 56.14% to $2.3 million in 2023, then rose by 10.17% to $2.5 million in 2024, then tumbled by 35.23% to $1.6 million in 2025.
  • Business Quant data shows Prepaid Assets for CRDF at $1.6 million in Q4 2025, $956000.0 in Q3 2025, and $2.2 million in Q2 2025.